Table 1 Demographic and clinical characteristics of HIV-1 patients receiving HAART
Characteristic | A (n = 88) | B (n = 38) | C (n = 50) | p-value |
|---|---|---|---|---|
Age (years) | 42 ± 8.6 | 41.4 ± 7.0 | 44.2 ± 8.2 | NS |
Sex (M/F) | 42/26 | 33/17 | 25/13 | NS |
BMI (kg/m2) | 23.51 ± 2.9 | 24.4 ± 1.8 | 23.4 ± 2.2 | NS |
PRFT/BMI | 0.2 ± 0.09 | 0.32 ± 0.01 | 0.13 ± 0.04 | < 0.0001 |
Current smoker (%) | 36.3 | 35.2 | 33.3 | NS |
Systolic pressure | 123 ± 6.8 | 126.9 ± 7.3 | 122.0 ± 6.7 | NS |
HIV exposure | Â | Â | Â | Â |
Homosexual | 42 (47.7%) | 23 (46%) | 19 (50%) | NS |
Heterosexual | 31 (35.2%) | 17 (34%) | 14 (36.8) | NS |
IDU | 15 (17%) | 8 (16%) | 7 (18.4%) | NS |
HCV coinfection (%) | 20.5 | 20 | 20.8 | NS |
CD4 (cells/μl) | 534.3 ± 251.6 | 533.8 ± 271.2 | 535 ± 212 | NS |
HIVRNA load (mean log10 copies) | 2.06 ± 1.2 | 2.1 ± 1.01 | 1.9 ± 1.4 | NS |
Duration of HAART (months) | 75 ± 40.9 | 82.4 ± 35.9 | 70.4 ± 43.6 | NS |
Total cholesterol (mg/dl) | 184.5 ± 44.7 | 190.3 ± 54.9 | 180.9 ± 37 | NS |
HDL cholesterol (mg/dl) | 51.5 ± 15 | 52.6 ± 16.2 | 50.8 ± 14.4 | NS |
Triglycerides (mg/dl) | 156.1 ± 94.7 | 177.3 ± 97.8 | 142.7 ± 91.3 | NS |
Glycemia (mg/dl) | 94.3 ± 11.8 | 92.8 ± 6.9 | 86.7 ± 9.2 | NS |
2 NRTI + 1 NNRTI | 41 (46.5%) | 23 (46%) | 18 (47.3%) | NS |
2 NRTI + 1 PI | 47 (53.4%) | 27 (54%) | 20 (52.6%) | NS |